VF
CTMX icon

Virtu Financial’s CytomX Therapeutics CTMX Stock Holding History

Virtu Financial’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-101,895
Closed -$479K – 1721
2026
Q1 		$479K Buy
+101,895
New +$517K 0.02% 592
2025
Q3 		– Sell
-35,136
Closed -$80K – 1576
2025
Q2 		$80K Buy
35,136
+23,339
+198% +$37.6K ﹤0.01% 1064
2025
Q1 		$8K Sell
11,797
-45,215
-79% -$35.1K ﹤0.01% 1205
2024
Q4 		$59K Sell
57,012
-31,506
-36% -$33.9K ﹤0.01% 1129
2024
Q3 		$104K Buy
+88,518
New +$112K 0.01% 901
2023
Q2 		– Sell
-24,136
Closed -$36K – 1603
2023
Q1 		$36K Buy
+24,136
New +$54.6K ﹤0.01% 1151
2022
Q1 		– Sell
-52,434
Closed -$227K – 1594
2021
Q4 		$227K Buy
+52,434
New +$307K 0.02% 773
2021
Q1 		– Sell
-14,051
Closed -$92K – 1663
2020
Q4 		$92K Buy
14,051
+986
+8% +$7.04K 0.01% 1083
2020
Q3 		$87K Buy
+13,065
New +$96.9K 0.01% 733
2018
Q2 		– Sell
-11,123
Closed -$316K – 2048
2018
Q1 		$316K Buy
+11,123
New +$317K 0.02% 1016
2017
Q4 		– Sell
-12,291
Closed -$223K – 2438
2017
Q3 		$223K Buy
+12,291
New +$192K 0.01% 1717

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Virtu Financial's CTMX Position: Q2 2026 in Review

Virtu Financial sold out of CytomX Therapeutics (CTMX) in Q2 2026, closing a stake of 101,895 shares — an estimated $479K sold.

Virtu Financial first reported a position in CTMX in Q3 2017 and held it in 11 quarters. The position peaked at $479K in Q1 2026. 178 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • Virtu Financial reported no remaining CytomX Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 101,895 CytomX Therapeutics shares in Q2 2026, an estimated $479K.
  • Virtu Financial first reported a position in CytomX Therapeutics in Q3 2017 and held it in 11 quarters.
  • Virtu Financial's CytomX Therapeutics position peaked at $479K in Q1 2026.
  • 178 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.